Rhythm Pharmaceuticals
RYTM
RYTM
116 hedge funds and large institutions have $1.09B invested in Rhythm Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 42 increasing their positions, 23 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
8% less funds holding
Funds holding: 126 → 116 (-10)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
26% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 38
Holders
116
Holding in Top 10
3
Calls
$3.8M
Puts
$194K
Top Buyers
| 1 | +$41M | |
| 2 | +$18M | |
| 3 | +$13.9M | |
| 4 |
Primecap Management
Pasadena,
California
|
+$11.4M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$11.1M |
Top Sellers
| 1 | -$12.7M | |
| 2 | -$9.76M | |
| 3 | -$5.2M | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$4.97M |
| 5 |
D.E. Shaw & Co
New York
|
-$4.96M |